Actuate Therapeutics ACTU
NASDAQ ACTU
$0.82 -0.07 (-7.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Cash & Equivalents (2024 - 2026)

Updated

Actuate Therapeutics' Cash & Equivalents was $4.43 million in Q2 2026, down 31.8% from $6.49 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Cash & Equivalents at Actuate Therapeutics came in at $13.16 million, up 52.3% from FY2024.

  • In earlier years, Cash & Equivalents was $8.64 million in FY2024.
  • The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 20.42 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 6.57 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 4.89 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 3.18 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 976.00 Mn
10 Actuate Therapeutics 21.37 Mn 21.37 Mn - 4.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.43 Mn
Dec 31, 2025 13.16 Mn
Sep 30, 2025 16.92 Mn
Jun 30, 2025 6.49 Mn
Mar 31, 2025 3.89 Mn
Dec 31, 2024 8.64 Mn
Sep 30, 2024 13.52 Mn
Jun 30, 2024 351,709.00
API Access

Actuate Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACTU&period=max&api_key=YOUR_API_KEY